Recent Finacing
Recent Raise
GliaCure is a Boston-based company developing non-neuronal therapies; lead candidate GC021109 is a small molecule that stimulates phagocytosis and reduces pro-inflammatory cytokines for Alzheimer’s and other disorders.
Focus Areas
Total Raised
Funding round